Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Borba, G. Naveso, C. Oliveira, E. Magro, C. Rocha, A. Mineiro, J. Cardoso (Lisbon, Portugal). Presence of cardiovascular risk markers in OSAS. Eur Respir J 2007; 30: Suppl. 51, 3499

Member's Comments

No comment yet.

Related content which might interest you: Metabolic effects of OSAS and cardiovascular risk Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 OSA and cardiovascular risk in women Source: 5th Sleep and Breathing Conference Year: 2019 OSAS and the incidence of cardiovascular disorders Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Cardiovascular risk markers in patients with OSA. Effects of CPAP treatment Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 The relationship between some oxidative stress markers and metabolic cardiovascular risk factors in the blood of different stage obstructive sleep apnea persons Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001 Correlates and assessment of excess cardiovascular risk in bronchiectasis Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017 Year: 2017 Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Prevalence and risk factors of depression in patients with COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 The association between COPD and cardiovascular disorders Source: International Congress 2017 – COPD and comorbid cardiovascular diseases Year: 2017 Is OSA an important risk factor for metabolic dysregulation in obese COPD patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Early cardiovascular disease markers in "healthy" OSA patients are correlated with sympathetic activity Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Relationship between sleep apnea syndrome, plasma myeloperoxidase levels and cardiovascular risk Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009